Regulon

Regulon: R-1400

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.3048418Pr-85Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
2817 ENSG00000063660 GPC1 P35052
6717 ENSG00000075142 SRI P30626
23541 ENSG00000100003 SEC14L2 O76054
8406 ENSG00000101955 SRPX P78539
55240 ENSG00000115107 STEAP3 A1P3F0
2152 ENSG00000117525 F3 P13726
57134 ENSG00000117643 MAN1C1 Q9NR34
10267 ENSG00000132329 RAMP1 O60894
1827 ENSG00000159200 RCAN1 P53805
9263 ENSG00000164543 STK17A Q9UEE5
1466 ENSG00000175183 CSRP2 Q16527
56674 ENSG00000175348 TMEM9B Q9NQ34
25840 ENSG00000185432 METTL7A A0A024R118

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
PRAMLINTIDERAMP1ProteinAGONISTAmylin receptor AMY1, CALCR/RAMP1 agonist40
PRAMLINTIDE ACETATERAMP1ProteinAGONISTAmylin receptor AMY1, CALCR/RAMP1 agonist40
TISOTUMAB VEDOTINF3AntibodyBINDING AGENTCoagulation factor III binding agent40
DAVALINTIDERAMP1ProteinAGONISTCalcitonin gene-related peptide type 1 receptor agonist20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1400

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-06884ATRXdown-regulatesTGIF1activatesR-140095Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-08692MYH14up-regulatesTGIF1activatesR-140092Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-15404DSEup-regulatesTGIF1activatesR-140094Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-20183PARP4up-regulatesTGIF1activatesR-140091Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-21353GRIK3up-regulatesTGIF1activatesR-140093Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-22537IDH1down-regulatesTGIF1activatesR-140096Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-23216RNF17up-regulatesTGIF1activatesR-140092Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE

CMF-23785TP53down-regulatesTGIF1activatesR-140094Drugs (4)

Regulator Drugs (0)

Regulon Drugs (4)

PRAMLINTIDE, PRAMLINTIDE ACETATE, TISOTUMAB VEDOTIN, DAVALINTIDE